Eton Pharmaceuticals, Inc. ETON Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.55M+199% | —— | -$1.93M-407% | -$2.59M+15.0% | -$1.57M-93.8% | ||
| $1.13M+11.6% | $1.02M+186% | $1.01M+263% | $1.01M+260% | $1.01M+333% | ||
| $1.52M+26.5% | $1.12M+43.7% | $1.09M+51.2% | $2.1M+150% | $1.2M+46.2% | ||
| $1.65M-85.0% | —— | —— | —— | $11.04M+1,232% | ||
| -$1.41M-293% | $581K-28.4% | —— | $11.27M— | -$358K-125% | ||
| $2.51M+256% | —— | $2.12M+284% | $7.27M— | $705K+70.3% | ||
| -$1.53M-11.6% | $426K-79.1% | $1.79M— | $172K— | -$1.37M+16.2% | ||
| -$1.75M+41.0% | $2.52M-28.4% | —— | —— | -$2.97M-3,663% | ||
| -$7K— | —— | —— | —— | -$0— | ||
| $9K-47.1% | $9K-87.1% | $5K-70.6% | $13K-27.8% | $17K-5.6% | ||
| $118K-59.9% | $175K-83.2% | $189K+552% | $48K+109% | $294K+1,076% | ||
| $7.41M+254% | —— | $12.03M+307% | $7.96M— | $2.09M+185% | ||
| $75K— | $49K+308% | $284K— | -$0— | -$0-100% | ||
| —— | -$0-100% | -$0-100% | -$0-100% | -$0-100% | ||
| $15M— | $0-100% | $0— | -$0— | -$0-100% | ||
| -$15.08M— | -$49K+99.9% | -$284K— | $0— | $0+100% | ||
| $1.39M+253% | $204K-79.9% | —— | —— | $394K+5,529% | ||
| $1.39M+253% | $421K-98.7% | —— | —— | $394K+204% | ||
| -$6.28M-353% | —— | $11.74M— | $7.96M— | $2.48M+152% | ||
| $881K+37.2% | $930K+564% | $1.54M+847% | $210K+22.1% | $642K+238% | ||
| $37K+363% | $1K— | $28K-84.5% | $81K— | $8K— | ||
| $118K-59.9% | $175K-83.2% | $189K+552% | $48K+109% | $294K+1,076% | ||
| $1.82M+183% | —— | —— | -$7.18M— | -$2.19M— | ||
| -$1.75M+41.0% | $2.52M-28.4% | —— | —— | -$2.97M-3,663% | ||
| $227K+106% | —— | —— | —— | $110K-16.8% | ||
| $9K-47.1% | $9K-87.1% | $5K-70.6% | $13K-27.8% | $17K-5.6% | ||
| -$7K— | —— | —— | —— | -$0— | ||
| —— | -$0-100% | -$0-100% | -$0-100% | -$0-100% | ||
| $15M— | $0-100% | $0— | -$0— | -$0-100% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $1.39M+253% | —— | —— | —— | $394K— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $1.82M-70.0% | —— | $1.81M+99.3% | $3.29M+13.7% | $6.07M+876% | ||
| $350K-69.4% | $1.42M— | $1.32M— | $1.21M— | $1.14M— | ||
| $37K+363% | $1K— | $28K-84.5% | $81K— | $8K— | ||
| $7.33M+251% | —— | $11.74M+298% | $7.96M— | $2.09M+184% | ||
| $7.33M+251% | —— | $11.74M+298% | $7.96M— | $2.09M+184% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Eton Pharmaceuticals, Inc. generate?
- Eton Pharmaceuticals, Inc. (ETON) generated $29.5M in operating cash flow over the trailing twelve months.
- What is Eton Pharmaceuticals, Inc.'s free cash flow?
- After $408.0K of capital expenditures, Eton Pharmaceuticals, Inc.'s free cash flow was $29.1M over the trailing twelve months, up 1588.2% year over year.
- Where does Eton Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
